Nicolas Mach is a medical Oncologist at the Geneva University Hospital (Dpt of Oncology), Head of the Clinical Research Unit, Vice-Director of the Cancer Centre at the Geneva University Hospital and Associate Professor at the Geneva Medical School (Dpt of Medicine).

He is also the founder and Chief Scientific Officer of MaxiVAX SA (a Geneva based biotech company, focusing on personalized, cell-based immunotherapy).